Product Information
LEVOTHYROXINE 50 MCG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.0407 per EA under NDC 69238183107. Its NADAC has been published 407 times since Dec 19, 2018.
FDA first approved this application on Aug 21, 2000. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.05 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238183107
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021210FDA Approved
8/21/2000
TE Code
AB1,AB2,AB3
On Market Since
12/1/2003
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 50 MCG TABLET has been published 407 times since Dec 19, 2018, and over the history we have for it it has declined 86.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0407 per EA |
|---|---|
| All-time high | $0.3039 (Apr 10, 2019) |
| All-time low | $0.0406 (Aug 19, 2026) |
| 52-week high | $0.0524 |
| 52-week low | $0.0406 |
| Median price | $0.1107 |
| Average price | $0.1432 |
| Largest weekly change | +35.8% (Jun 19, 2024) |
| Weeks tracked | 407 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levothyroxine Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Thyroxine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 50 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 50 MCG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.0407 per EA (NDC 69238183107), effective Sep 30, 2026.
How has the price of LEVOTHYROXINE 50 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 50 MCG TABLET has declined 86.1%. It has been tracked across 407 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 50 MCG TABLET?
Since Dec 19, 2018, the NADAC for LEVOTHYROXINE 50 MCG TABLET has ranged from a low of $0.0406 (Aug 19, 2026) to a high of $0.3039 (Apr 10, 2019), with a median of $0.1107 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 50 MCG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 50 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 50 MCG TABLET?
LEVOTHYROXINE 50 MCG TABLET (NDC 69238183107) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.